Legislation


SB 566 – Rhode Island

Status: In Process
Year Introduced: 2023
Link: http://webserver.rilegislature.gov/BillText/BillText23/SenateText23/S0566.pdf

Establishes a process whereby large drug manufacturers, may be penalized for prescription drug price increases where there is no, or inadequate, new evidence to support the price increase.


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found